年轻成人髋关节盂唇撕裂关节镜治疗的最小10年生存率与结局
该病例系列(证据等级4)前瞻性收集并回顾性分析2008年6月至2012年8月接受初次髋关节镜盂唇修复或清创的19至40岁患者,194髋(80.5%)完成至少10年随访;10年生存率为91.8%,所有患者报告结局指标(PROMs)较基线显著改善,mHHS的PASS及mHHS、NAHS、VAS-Pain的MCID达成率高。
要点
- 年轻成人初次髋关节镜盂唇治疗后10年生存率为91.8%。
- 所有PROMs从基线至至少10年随访显著改善(P < .05)。
- mHHS的PASS及mHHS、NAHS、VAS-Pain的MCID达成率高。
核心结论
- 年轻成人接受初次髋关节镜盂唇治疗后的总体10年生存率为91.8%,PROMs显著改善,mHHS的PASS及mHHS、NAHS、VAS-Pain的MCID达成率高。
研究设计与样本
- 病例系列,证据等级4;前瞻性收集并回顾性分析2008年6月至2012年8月接受初次髋关节镜的患者。
- 纳入年龄>19且<40岁、接受盂唇清创修复或重建及伴随手术的年轻成人患者。
- 排除标准为同侧髋既往手术/病变、Tönnis分级>1、髋关节发育不良、工伤补偿状态或股骨头与髋臼Outerbridge评分4分。
主要发现
- 241髋符合分析条件,194髋(80.5%)完成至少10年随访;122名女性(62.9%)和72名男性(37.1%),平均年龄28.9岁,平均体重指数24.8 kg/m2。
- 年轻成人患者的10年生存率为91.8%,12.9%的患者在初次手术后平均36.8个月接受同侧后续关节镜。
- 所有PROMs从基线至至少10年随访显著改善(P < .05),包括mHHS、NAHS、HOS-SSS、VAS-Pain、iHOT-12和患者满意度。
- 19至40岁患者在mHHS、NAHS和VAS-Pain上MCID达成率高,mHHS的PASS达成率高。
关键数值与推荐
- 10年生存率(免于转为全髋关节置换术)为91.8%。
- 12.9%的患者在初次手术后平均36.8个月接受同侧后续关节镜。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have shown good mid-term outcomes of hip labral tear treatment with arthroscopy. However, long-term results are limited within the young adult population. PURPOSE: To report survivorship and patient-reported outcome measures (PROMs) at a minimum 10-year follow-up in young adult patients after primary hip arthroscopy with labral repair or debridement. STUDY DESIGN: Case Series; Level of evidence, 4. METHODS: Data were prospectively collected and retrospectively reviewed on all patients who underwent primary hip arthroscopy between June 2008 and August 2012. Young adult patients, aged >19 and <40 years, who underwent labral debridement repair or reconstruction and concomitant procedures were included. Preoperative and minimum 10-year follow-up data for the modified Harris Hip Score (mHHS), Non-Arthritic Hip Score (NAHS), Hip Outcome Score-Sport-Specific Subscale (HOS-SSS), iHOT-12 (International Hip Outcome Tool), and visual analog scale for pain (VAS-Pain) were collected. The exclusion criteria were previous ipsilateral hip surgery/conditions, Tönnis grade >1, hip dysplasia, workers' compensation status, or femoral head and acetabular Outerbridge scores of 4. Rates of achieving the minimal clinically important difference (MCID) and the patient acceptable symptomatic state (PASS), as well as hip joint survival from conversion to total hip arthroplasty and progression to subsequent ipsilateral revision hip arthroscopy, were reported. RESULTS: Of the 241 hips eligible for analysis, 194 hips (80.5%) had a minimum 10-year follow-up. A total of 122 women (62.9%) and 72 men (37.1%) were included in the present analysis, with a mean age of 28.9 years and a mean body mass index of 24.8 kg/m2. The 10-year survivorship for young adult patients was 91.8%, and 12.9% of patients underwent subsequent ipsilateral arthroscopy at a mean of 36.8 months after the initial procedure. Significant improvements were observed in all PROMs from baseline to a minimum 10-year follow-up-including the mHHS, NAHS, HOS-SSS, VAS-Pain, iHOT-12, and patient satisfaction (P < .05). Patients aged 19 to 40 years achieved high rates of MCID, for mHHS, NAHS, and VAS-Pain, as well as high rates of PASS for the mHHS. CONCLUSION: Young adults who underwent primary hip arthroscopy with labral treatment demonstrated an overall 10-year survivorship of 91.8%, significant improvements in PROMs, and high achievement rates of PASS for the mHHS and MCID for the mHHS, NAHS, and VAS-Pain.
引用
- Domb BG, Bruning RE, Curley AJ, et al. Minimum 10-Year Survivorship and Outcomes of Arthroscopic Treatment of Hip Labral Tears in Young Adults. Am J Sports Med. 2026. PMID: 41549479. doi:10.1177/03635465251395292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。